IPO Boutique Research, Color & More Information for Subscribers
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Conatus Pharmaceuticals, Inc. Symbol: CNAT Price: Last trade $6.80 Trade Date: 4/2 Shares: 2.9 million Underwriter(s) Stifel, Roth Capital Partners Rating=Subscription[…]